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Abstract
Background. Family studies point to important genetic
determinants of diabetic nephropathy (DN). Blood
pressure (BP) is higher in offspring of patients with
type 2 diabetes and DN, but the pathomechanisms
involved have not been elucidated.
Methods. We examined the salt sensitivity of BP
after 5 days equilibration on a low (20mmol/day)
vs high salt diet (220mmol/day) in three matched
groups of 15 subjects each: (i) control individuals;
(ii) offspring of type 2 diabetic parents without
DN (DN); and (iii) offspring of type 2 diabetic
parents with DN (DNþ). Ambulatory BP and
hormones involved in sodium homeostasis [plasma
renin activity (PRA), aldosterone and atrial natriuretic
peptide (ANP)] as well as the tetrahydrocortisolþ
5-allotetrahydrocortisol/tetrahydrocortisone (THFþ
5aTHF)/THE) ratio in the urine as an index of
11b-hydroxysteroid dehydrogenase type 2 (11bHSD2)
activity were analysed.
Results. In offspring of DNþ patients on a high salt
diet, systolic and diastolic BP was 137/82±10/8mmHg
vs 125/77±12/8mmHg in offspring of DN patients
(P<0.01 for systolic BP). The salt-induced difference
in mean BP between high and low salt diet was
5.2±3.3mmHg in offspring of DNþ patients vs
0.7±4.7mmHg in offspring of DN patients
(P<0.002). The proportion of ‘salt-sensitive’ individ-
uals was 67% in offspring of DNþ patients vs 20% in
offspring of DN patients (P<0.05). In all groups,
a high salt diet caused a comparable decrease of PRA
and p-aldosterone accompanied by an increase in
ANP. The urinary (THFþ 5aTHF)/THE ratio was
1.23±0.36 in salt-sensitive individuals and 0.99±0.33
(P<0.03) in salt-resistant subjects, consistent with
increased activity of 11bHSD2.
Conclusions. BP is more salt sensitive in offspring
of type 2 diabetic patients with diabetic nephropathy.
The salt sensitivity of BP may be an intermediate
phenotype in individuals with a high risk of future
diabetic nephropathy.
Keywords: diabetic nephropathy; hypertension;
intermediate phenotype; salt sensitivity
Introduction
Diabetic nephropathy (DN) is observed in up to
30% of patients who suffer from type 2 diabetes for
>10 years [1–3]. Familial clustering [4,5] and a high
frequency of cardiovascular accidents in ﬁrst-degree
relatives of patients with type 2 diabetes and DN [6]
also point to strong independent genetic determination.
We and others observed higher rates of albumin
excretion in (pre-diabetic) offspring of type 2 patients
with DN [7,8]. We also observed that blood pressure
(BP) was higher in the offspring of patients with type 2
diabetes with DN as opposed to offspring of patients
with type 2 diabetes without DN [7]. These ﬁndings
raised the issue of whether BP was linked to the risk of
development and/or progression of DN. Such a link
between BP and glomerular disease is not unique to
diabetic renal disease. Schmid et al. found a higher
prevalence of hypertension in parents of patients
with glomerulonephritis as compared with matched
non-glomerulonephritis individuals [9]. Furthermore,
Fagerudd et al. measured ambulatory BP in parents
whose offspring had type 1 diabetes either with or
without DN [10]. Blood pressure by ambulatory BP
monitoring was signiﬁcantly higher in parents whose
offspring suffered from DN, arguing for a link between
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a genetic predisposition to hypertension on the one
hand and to glomerular disease on the other hand.
The enzyme 11b-hydroxysteroid dehydrogenase
type 2 (11bHSD2) is a potential candidate for abnormal
BP regulation in hypertension and renal diseases [11].
In mineralocorticoid target tissues, 11bHSD2 inacti-
vates cortisol into cortisone, thus protecting the
non-speciﬁc mineralocorticoid receptor from excess
activation by glucocorticoids. The enzyme is expressed
in the cortical collecting duct of the kidney.
In an effort to deﬁne potential intermediate pheno-
types predisposing to nephropathy in type 2 diabetes
more clearly, we assessed (i) salt sensitivity of BP and
(ii) hormonal responses to low salt and high salt diets
in non-diabetic normotensive offspring of patients
with type 2 diabetes, i.e. patients who either had
developed or failed to develop DN after at least
10 years duration of diabetes.
Subjects and methods
Description of study cohort
We identiﬁed a group of 30 type 2 diabetic patients [12]
with known duration of diabetes of >10 years who were
followed in a tertiary care centre (Regional Outpatient Clinic
for Diabetics in Zabrze, Poland) and who had healthy
offspring available for the study. Mean age was 63±5 years
and known duration of diabetes 13±2 years.
Fifteen diabetic parents had DN: ﬁve were on renal
replacement therapy and 10 had proteinuria (>0.5 g/24 h).
The presence of non-diabetic renal disease was excluded by
clinical evaluation (phase contrast microscopy of urinary
sediment, renal ultrasonography and clinical work-up).
A further 15 diabetic parents had a similar duration
of diabetes. They had normoalbuminuria (<30mg/24 h on
three occasions during the 6 months preceding the study).
Exclusion criteria for the offspring were casual BP
>140/90mmHg under resting conditions and fasting plasma
glucose >110mg/dl. Furthermore, smokers and female
subjects using oral contraceptives were excluded. We studied
a total of 15 offspring of type 2 diabetic patients without
nephropathy (DN) and 15 offspring of type 2 diabetic
patients with nephropathy (DNþ). Staff members (n¼ 15)
without a family history of diabetes mellitus, coronary artery
disease or hypertension and satisfying the above criteria
were selected as controls. Clinical characteristics of the
examined subjects are given in Table 1.
All subjects gave written informed consent. The protocol
was approved by the ethics Committee of the SilesianMedical
Academy in Katowice. The study was executed in the
Department of Internal Medicine and Diabetology Silesian
Medical Academy (Zabrze, Poland), and was conducted in
accordance with the guidelines proposed in the Declaration of
Helsinki.
All subjects underwent an identical protocol consist-
ing of two 5 day study periods in sequential order, i.e.
a low followed by a high salt diet on an out-patient
basis. They received a pre-cooked diet with deﬁned NaCl
content. Daily 24 h urine collections were used to monitor
urinary sodium excretion throughout the study, to assess
protein intake by urea nitrogen excretion and to measure
the urinary tetrahydrocortisolþ 5-allotetrahydrocortisol/
tetrahydrocortisone (THFþ 5aTHF)/THE) ratio at the end
of the low salt period. High salt intake was achieved by
adding slow-release sodium chloride tablets providing a
daily NaCl intake of 220mmol/day. Ambulatory BP was
recorded on the ﬁfth day of each study period. Blood was
taken at 8.00 a.m. in the fasting state after 30min in the
supine position for biochemical and hormonal measurements,
as well as body weight measured on day 0 and day 5 of
each study period.
Analytical methods
Continuous BP recordings were obtained using Medilog
DX System (Oxford, UK). Night-time pressure was deﬁned as
BP between 24:00 and 06:00 h. Salt sensitivity of BP was
evaluated according to Sharma et al. [13]. According to his
proposal, BP was categorized as salt sensitive when the
increment of 24 h mean arterial pressure (MAP) on a high
salt diet exceeded 3mmHg compared with the period on a
low sodium diet.
Blood and urine chemistries were measured using an
autoanalyser technique; haemoglobin A1c (HbA1c) using the
high-performance liquid chromatography method on a
BioRad Variant analyser (Bio-Rad Laboratories, Hercules,
CA); haematocrit by centrifugation; plasma renin activity
(PRA), aldosterone, immunoreactive insulin and atrial
natriuretic peptide (ANP), and urinary albumin concentra-
tions using radioimmunoassays. The urinary steroid metabo-
lites THFþ 5aTHF) and THE were assessed by gas
chromatography as described previously [11,14].
Statistics
Data are given as means±SD (if normally distributed) or
median and range (if not normally distributed). The zero
hypothesis was rejected at P<0.05 by non-parametric
analysis using the Wilcoxon’s or Mann–Whitney tests or by
analysis of variance (ANOVA) using the SAS statistical
Table 1. Anthropometric and blood chemistry data of the
examined groups
Controls
(n¼ 15)
Offspring of type 2
diabetic patients
DN
(n¼ 15)
DNþ
(n¼ 15)
Age (years) 36±7 38±8 38±5
Gender (M/F) 2/13 4/11 7/8
Fasting glycaemia
(mg/dl)
79±8 79±8 81±5
HbA1c (%) 5.4±0.4 5.4±0.4 5.4±0.3
BMI (kg/m2) 22.5±3.1 25.1±3.44a 27.2±4.22b
S-creatinine (mg/dl) 0.86±0.18 0.93±0.21 0.90±0.23
S-cholesterol (mg/dl) 202±48.8 210±35.3 218±37.2
S-triglycerides (mg/dl) 125±53.6 131±50.1 128±76.5
LVMI (g/m2) 97.7±12.5 93.7±13.1 107±21.4
Kidney length (mm) 108±5.64 108±6.71 117±8.74
aP<0.05 vs the control group.
bP<0.01 vs the control group.
LVMI¼ left ventricular mass index; BMI¼body mass index.
2114 K. Strojek et al.
software program (SAS, Cary, NC). Bonferroni correction
for repeated measures was made as indicated.
Results
Baseline data (Table 1)
Offspring of type 2 diabetic DNþ and DN were well
matched with respect to age, gender, fasting glycaemia
and HbA1c. The latter parameters proved the absence
of diabetes in the subjects investigated. As a potential
reﬂection of a more marked predisposition to the
metabolic syndrome, the body mass index was sig-
niﬁcantly higher in offspring of DNþ patients than
in offspring of DN patients or in controls. Normal
renal function was veriﬁed by normal serum creatinine
values and estimated glomerular ﬁltration rate (data
not shown).
Ancillary measurements during low and
high salt periods (Table 2)
A signiﬁcant increase in body weight and a signiﬁcant
decrease in haematocrit in all three study groups
documented salt and volume retention during the
high salt period. Good compliance was reﬂected by
urinary sodium excretion rates closely corresponding to
the target sodium intakes. Urinary albumin excretion
was similar in all groups.
Blood pressure (Figures 1 and 2, and Table 3)
The pre-deﬁned primary end-point of the study was
the change of 24 h MAP in response to the switch over
from low to high salt intake. As illustrated in Figure 1,
there was a marked and signiﬁcant (P<0.002) differ-
ence between offspring of DNþ patients and offspring
of DN patients or control subjects, respectively.
Table 2. Ancillary measurements during low and high salt periods
Controls Offspring DN Offspring DNþ
Low salt High salt Low salt High salt Low salt High salt
Body weight (kg) 62±11b 64±11 68±13b 70±13 79±16b 80±16
Haematocrit (%) 42±4b 39±4 43±4b 38±3 42±4b 39±3
S-Na (mmol/l) 141±2 141±2 141±3 142±2 142±3 143±4
S-K (mmol/l) 4.5±0.3 4.2±0.5 4.6±0.4 4.5±0.3 4.4±0.4 4.5±0.4
UVNa (mmol/day) 14±6
b 241±27 16±6b 269±48 16±9b 264±29
UVK (mmol/day) 49±26 39±15 50±23
a 55±22 71±18 60±25
Protein intake (g/24 h) 38±8 40±11 51±15 41±15 54±15 45±12
Fasting insulin (mIU/l) 7.7 (3.0–24.3) 10.2 (2.2–37.1) 12 (1.7–31.7) 15.1 (0.7–33.4) 14.0c (4.4–41.1) 17.6 (0.2–32.1)
Albuminuria (mg/24 h) 21.0 (5.9–59.4) 23.4 (6.9–50.6) 13.6 (6.6–52.2) 18.9 (10.8–36.1) 18.1 (7.3–36.3) 21.4 (7.2–70.5)
Results are in means±SD or in median (range), n¼ 15 per group.
aP<0.05 low vs high salt intake.
bP<0.01 low vs high salt intake.
cP<0.05 vs control on low salt.
Fig. 1. Difference of the average mean arterial pressure (MAP)
by ambulatory 24 h measurement on low compared with high
dietary intake of sodium between examined offspring groups.
Controls¼ offspring of non-diabetic patients; DN¼ offspring of
diabetic patients without diabetic nephropathy; DNþ¼offspring of
diabetic patients with nephropathy. Taking MAP as a continuous
variable, differences between DNþ vs DN or controls were highly
signiﬁcant (P<0.002).
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As shown in Figure 2, consistently higher MAP values
were found during daytime and night-time in offspring
of patients with DN.
Table 3 shows systolic and diastolic BP and heart
rate during the low and high salt periods in the
three groups studied. In offspring of DNþ patients,
a signiﬁcant increase of systolic and diastolic BP was
observed on high salt intake. No signiﬁcant increment
of BP on high salt intake was found in offspring of
DN patients and control subjects. Nevertheless
night-time systolic BP on low salt intake in the group
of offspring of DNþ patients was signiﬁcantly higher
than in controls. On high salt intake, systolic BP
(daytime, night-time and 24 h) was signiﬁcantly higher
in offspring of DNþ patients when compared with
offspring of DN patients and control subjects.
On high salt intake, diastolic BP (daytime and night-
time) was signiﬁcantly higher in the offspring of DNþ
patients when compared with controls.
Using established and generally accepted criteria [12]
three out of 15 offspring of DN diabetic patients
and 10 out of 15 DNþ patients were salt sensitive
(P<0.05). The respective proportion for the control
group was four out of 15. The heart rate was
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Fig. 2. Mean circadian blood pressure proﬁle on low and high dietary salt intake in offspring of diabetic patients without diabetic
nephropathy (open squares) and with diabetic nephropathy (þ). aP<0.05 and aaP<0.01 high vs low salt, *P<0.01 DNþ vs DN.
Table 3. Systolic and diastolic blood pressure during low and high salt intake
Low salt period High salt period
Daytime Night-time 24 h Daytime Night-time 24 h
Systolic BP (mmHg) Control 123±9 111±9b 120±9 125±9b 110±6b 122±9a
DN 123±11 115±16 120±12 125±12b 113±16a 121±12b
DNþ 129±13 121±15 128±13 137±10d 128±16 135±11d
Diastolic BP (mmHg) Control 76±6 65±3 74±5 76±6a 67±4b 74±5
DN 77±9 69±11 75±9 77±8 67±14 75±8
DNþ 77±8 66±9 75±8 82±8d 77±12d 79±7c
Heart rate (/min) Control 90±9 69±7 85±8 83±10 69±9 80±9
DN 83±8 71±10 80±8 83±9 70±7 79±9
DNþ 85±7 69±11 81±7 83±8 68±11 80±8
Results are in means±SD, n¼ 15 per group.
aP<0.05 vs DNþ.
bP<0.01 vs DNþ.
cP<0.05 high vs low salt intake.
dP<0.01 high vs low salt intake.
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comparable in all study groups. It was not different
between the periods of low and high salt intake.
Hormonal measurements (Table 4)
PRA, plasma aldosterone and ANP did not differ
signiﬁcantly between the study groups during low and
high salt intake, respectively.
Urinary steroid metabolites (Figure 3)
The urinary (THFþ 5aTHF)/THE ratio at the end of
the low salt period was 0.97±0.31 in controls,
1.24±0.36 in offspring of DNþ patients (P<0.05 vs
controls) and 1.04±0.36 in offspring of DN patients.
The individual values are displayed in Figure 3.
There was a signiﬁcant difference of the urinary
(THFþ 5aTHF)/THE ratio between salt-sensitive indi-
viduals (n¼ 15) and salt-resistant individuals (n¼ 30),
i.e. 1.23±0.36 vs 0.99±0.33 (P<0.02).
Discussion
The present study shows that BP is more salt sensitive
in offspring of type 2 diabetic patients with DN as
compared with offspring of type 2 diabetic patients
without DN despite a similar duration of diabetes.
This ﬁnding is compatible with the notion that salt
sensitivity is an intermediate phenotype related to the
pathogenesis of DN.
There is no universally accepted deﬁnition of salt
sensitivity. We adopted a modiﬁed and generally
accepted version of the procedure proposed by
Sharma et al. [13]. We are conscious of the fact that
to categorize individuals as salt sensitive or salt
insensitive is somewhat arbitrary. However, the differ-
ence of BP responses to changes in dietary sodium
was still signiﬁcantly different between the groups
when the BP was treated as a continuous variable.
The study has certain limitations. We took great
care to make certain that the subjects were in sodium
equilibrium after 5 days. Equilibrium was clearly
documented by daily measurements of urinary
sodium as in a past study [15]. The subjects were
remarkably compliant and this was reﬂected by the
measured urinary sodium excretion rates. Based on
fasting glycaemia, the study subjects were all non-
diabetic, even if the recent downward revision of
fasting glycaemia criteria is taken into consideration.
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Fig. 3. Ratio of cortisol to cortisone metabolites in the urine
(THFþ 5aTHF/THE ratio) at the end of the low salt diet. Salt-
sensitive individuals (þ), salt-resistant individuals (ﬁlled circles).
Controls¼ offspring of non diabetic patients; DN¼ offspring of
diabetic patients without diabetic nephropathy; DNþ¼offspring of
diabetic patients with nephropathy. A signiﬁcant difference between
salt-sensitive and salt-resistant subjects was found (1.23±0.36 vs
0.99±0.33, P<0.02) when all subjects were considered as two
groups.
Table 4. Hormonal measurements in low and high salt periods
Low salt High salt
PRA (ng/ml/h) Controls 4.9±2.4a 0.6±0.7
DN 5.5±2.9a 0.8±1.2
DNþ 4.9±1.9a 0.8±0.7
Aldosterone (pg/ml) Controls 157±77.7b 22±4
DN 151±66b 26±9
DNþ 134±50b 23±13
ANP (pmol/l) Controls 19±10 22±11
DN 17±9 20±11
DNþ 21±10 21±10
Results are means±SD, n¼ 15 per group.
Offspring of patients without (DN) or with (DNþ) nephropathy.
aP<0.05 high salt vs low salt.
bP<0.01 high salt vs low salt.
PRA¼ plasma renin activity; ANP¼ atrial natriuretic peptide.
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The study thus includes individuals at high genetic risk
of diabetes mellitus, but without demonstrable pre-
diabetes or diabetes. Some hint of a latent pre-diabetic
state may be the fact that the body mass index was
higher and kidney size tended to be greater (in DNþ),
even though normal glucose and HbA1c levels indi-
cated normal glucose tolerance.
We took care to exclude obvious confounding
factors such as hormonal contraception in females.
All study subjects had no medication whatsoever that
could have confounded BP measurements.
The observation of higher BP in offspring of type 2
diabetic patients with DN conﬁrms our previous
ﬁnding [7]. Higher BP was associated with a higher
left ventricular mass index (LVMI), but we cannot
exclude confounding by insulin concentrations. Several
possibilities to explain the increased salt sensitivity of
BP were considered. The offspring of diabetic patients
tended to have higher insulin concentrations and thus
might possibly have had a more marked metabolic
syndrome. This possibility would also be in line with
the observation of a signiﬁcantly higher body mass
index. Renal ultrasonography showed a tendency for
kidneys to be larger (Table 1).
It is possible that higher pre-diabetic BP predisposes
to future DN. This hypothesis is supported by the
observation of Nelson et al. that pre-diabetic BP
determines the risk of DN after onset of type 2
diabetes, at least in Pima Indians [16]. It would also
be consistent with the observation that BP values and
frequency of hypertension are higher in families where
there is at least one propositus with diabetic [17] or non-
diabetic glomerular disease. In this context, one could
also refer to the hypothesis of Brenner and Chertow
[18] that individuals predisposed to hypertension
and renal disease have lower numbers of nephrons.
This hypothesis has to some extent been conﬁrmed,
at least as far as hypertension is concerned [19].
We acknowledge, however, that we cannot distinguish
whether salt sensitivity of BP is causally linked to
hypothetical future nephropathy, whether it is caused
by a latent renal abnormality predisposing to nephro-
pathy, e.g. nephron underdosing, or whether it is an
epiphenomenon caused by some confounding factor.
Salt sensitivity of BP is noted in a high proportion of
type 1 diabetic patients even in the absence of
nephropathy, but salt sensitivity is also a well known
characteristic of established DN [15]. Tuck et al.
found salt-sensitive BP in hypertensive, but not
non-hypertensive patients with type 2 diabetes [20].
Several factors have been implied for the tendency
of diabetes to cause Na retention, i.e. increased renal
tubular Na-K-ATPase or Naþ/proton exchange,
increased action of aldosterone and increased proximal
tubular sodium reabsorption via the Na–glucose
co-transporter. The latter is presumably excluded in
the present study because of the consistent absence of
glycosuria.
Conﬁrming previous results in our laboratory
[14], we found a signiﬁcantly higher urinary
(THFþ 5aTHF)/THE ratio in salt-sensitive than
in salt-resistant individuals, indicating a decreased
11bHSD2 activity. Although we are fully aware of
the limited biostatistical power because of the
relatively small sample size, it is remarkable that a
tendency for decreased 11bHSD2 activity in salt-
sensitive individuals was noted even in this relatively
small sample. Increased salt sensitivity as a potential
intermediate phenotype may be of interest to the
geneticist. Salt sensitivity has recently been related
to adducin [21], the epithelial sodium channel of the
distal tubule and cortical collecting ducts [22], and
to 11bHSD2 enzyme [11,14]. A recent communication
found changes in 11bHSD2 expression and activity
in experimental diabetes [23], but acquired changes
in enzyme activity are not an issue in the present study.
We conclude that the present study documents
greater salt sensitivity of BP in offspring of diabetic
parents with DN. Whether salt sensitivity is an
intermediate phenotype predisposing to future DN
requires further investigation.
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